Skip to main content
GuidehouseGuidehouse
Guidehouse
  • Industries
    All Industries
    Industries
    • Communities, Energy & Infrastructure
    • Defense & Security
    • Financial Services
    • Health
    • State & Local Government
    Europe, Middle East & Canada

    Europe, Middle East & CanadaShaping industries with global scale

  • Services
    All Services
    Services
    • AI & Data
    • Energy & Resilience
    • Finance & Revenue
    • Managed Services
    • Mission Enablement
    • Operations & Efficiency
    • People, Organization & Change
    • Risk, Regulatory & Compliance
    • Technology
  • Insights
    All Insights
    Insights
    2026 Trends Guide
    • Energy Providers
    • Government Agencies
    • Financial Services
    • Health
    featured content

    The GuideLine podcast: Finding balance through fast tech and high stakes

  • Careers
    All Careers
    Careers
    • Early Career
    • Contractors
    • Experienced Professionals
    • Veterans & Military
    Help Guide the Future

    Search & Apply for Jobs

  • About
    About Guidehouse
    About
    • Community Impact
    • Government Contract Vehicles
    • D.C. United Partnership
    • Ecosystem Partners
    • Europe, Middle East & Canada
    • Legal
    • News & Events
    • Leadership
    • Privacy Policy
    Guidehouse in
    DeutschlandIndiaLietuvaUnited KingdomView offices
Article

Rare Diseases: How To Leverage Social Media For Patient Analysis

Publicly available online and social media data offers life sciences companies a pioneering way to access an abundance of previously unattainable insights.

July 19, 2021
How to leverage social media for patient analysis
July 19, 2021

For life sciences companies struggling to find crucial insights into rare diseases, the internet offers a trove of public data to tap into to learn more. As many as 7,000 rare conditions together affect an estimated 25 to 30 million Americans in total. While breakthroughs for novel therapies offer a promising way to shift the macabre trajectory of some life-threatening rare diseases, many more await remedies. The small, often dispersed populations make studying them, developing treatments, and recruiting for clinical trials extremely difficult.

By Youbean Oak and Paige Cooper

This byline originally appeared in Cell & Gene

 

MORE ON THIS TOPIC

  • Opportunity’s Knocking: Open the Door to These Next-Gen Field Team Strategies
  • Three Steps to Consider When Launching a Product in Today’s Market
  • Why Life Sciences Companies Require a Comprehensive Approach to Defend Against Cyberattacks

Let us guide you

Guidehouse is a global AI-led professional services firm delivering advisory, technology, and managed services to the commercial and government sectors. With an integrated business technology approach, Guidehouse drives efficiency and resilience in the healthcare, financial services, energy, infrastructure, and national security markets.

Get in touch with our experts:

Stay ahead of the curve with our latest insights, expertly tailored to your industry.

Logo

outwit complexity™

Logo

outwit complexity™

Connect with us

Industries

  • Communities, Energy & Infrastructure
  • Defense and Security
  • Financial Services
  • Health
  • State & Local Government

Services

  • AI and Data
  • Energy & Resilience
  • Finance & Revenue
  • Managed Services
  • Mission Enablement
  • Operations
  • People Organization & Change
  • Risk, Regulatory & Compliance
  • Technology

About

  • Community Impact
  • D.C. United Program
  • Ecosystem Partners
  • General Inquiries
  • Government Contract Vehicles
  • Legal / Policies
  • Our Leadership
  • Privacy Policy
Insights
Careers
News & Events
Offices
  • Guidehouse In
  • Deutschland
  • India
  • Lithuania
  • United Kingdom
  • Privacy Notice for CA Residents
  • Modern Slavery Statement
  • Do Not Sell / Share My Personal Information
  • Cookie Settings & Do Not Sell My Personal Info
  • Global Human Rights Statement

© 2026 Guidehouse